We are live on
!
Find out more
BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$11.3B
1-Year Est. Return
35.84%
This Fund
S&P 500
This Quarter
Est. Return
-4.88%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$10.4B
AUM Growth
-$5.16B
(-33%)
Cap. Flow
-$5.08B
Cap. Flow
% of AUM
-48.89%
Top 10 Holdings %
Top 10 Hldgs %
72.55%
Holding
1,549
New
555
Increased
320
Reduced
229
Closed
427
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$83.9M |
| 2 |
NVIDIA
NVDA
|
+$75.9M |
| 3 |
Pfizer
PFE
|
+$57.8M |
| 4 |
Blackrock
BLK
|
+$42.6M |
| 5 |
Meta Platforms (Facebook)
META
|
+$39.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$212M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$186M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$150M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$94.2M |
| 5 |
Pampa Energía
PAM
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.64% |
| 2 | Financials | 4.58% |
| 3 | Industrials | 2.27% |
| 4 | Healthcare | 2.17% |
| 5 | Consumer Discretionary | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLG
1076
Platinum Group Metals
PLG
$200M
| $61K | ﹤0.01% |
50,000
| – | – |
|
1077
Ginkgo Bioworks
DNA
$506M
| $57.8K | ﹤0.01% |
+10,145
| New | +$103K |
|
1078
Prime Medicine
PRME
$579M
| $56.7K | ﹤0.01% |
+28,478
| New | +$72.6K |
|
1079
Bridger Aerospace
BAER
$75.3M
| $56.5K | ﹤0.01% |
+50,000
| New | +$110K |
|
1080
Evolution Petroleum
EPM
$134M
| $55.8K | ﹤0.01% |
+10,774
| New | +$56.2K |
|
1081
Ironwood Pharmaceuticals
IRWD
$687M
| $50.9K | ﹤0.01% |
+34,658
| New | +$82.5K |
|
1082
4D Molecular Therapeutics
FDMT
$586M
| $47.8K | ﹤0.01% |
+14,800
| New | +$69.7K |
|
|
ESPR
1083
DELISTED
Esperion Therapeutics
ESPR
| $47.4K | ﹤0.01% |
+32,933
| New | +$60.7K |
|
1084
Neumora Therapeutics
NMRA
$304M
| $46.3K | ﹤0.01% |
46,254
-34,305
| -43% | -$58.7K |
|
1085
Solid Power
SLDP
$559M
| $46.1K | ﹤0.01% |
+43,913
| New | +$60.1K |
|
|
CGC
1086
Canopy Growth
CGC
$420M
| $45K | ﹤0.01% |
50,000
| – | – |
|
1087
Definitive Healthcare
DH
$69.6M
| $44.1K | ﹤0.01% |
+15,255
| New | +$61.9K |
|
|
SGMO
1088
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $43.6K | ﹤0.01% |
+66,018
| New | +$69.9K |
|
1089
CS Disco
LAW
$277M
| $43.4K | ﹤0.01% |
+10,608
| New | +$51.5K |
|
1090
United States Antimony
UAMY
$968M
| $43.4K | ﹤0.01% |
+19,715
| New | +$34.2K |
|
1091
Eledon Pharmaceuticals
ELDN
$280M
| $41K | ﹤0.01% |
+12,080
| New | +$49.7K |
|
1092
Amylyx Pharmaceuticals
AMLX
$2.59B
| $40.1K | ﹤0.01% |
+11,330
| New | +$40.3K |
|
|
SRG
1093
Seritage Growth Properties
SRG
$136M
| $35.6K | ﹤0.01% |
+11,028
| New | +$40.4K |
|
1094
Protalix BioTherapeutics
PLX
$196M
| $34.5K | ﹤0.01% |
+13,474
| New | +$32.2K |
|
1095
BuzzFeed Inc Warrant
BZFDW
$659K
| $33.2K | ﹤0.01% |
603,324
| – | – |
|
1096
Montauk Renewables
MNTK
$248M
| $33.2K | ﹤0.01% |
15,863
-3,010
| -16% | -$11K |
|
|
DHC
1097
Diversified Healthcare Trust
DHC
$1.98B
| $31.2K | ﹤0.01% |
+12,993
| New | +$32.1K |
|
1098
Kaltura
KLTR
$249M
| $30.4K | ﹤0.01% |
+16,146
| New | +$36.1K |
|
1099
Vuzix
VUZI
$222M
| $28.7K | ﹤0.01% |
+14,070
| New | +$46.1K |
|
1100
Holley
HLLY
$392M
| $28.6K | ﹤0.01% |
+11,113
| New | +$31.2K |
|
Similar funds
GKIM
DCP
VLKIM
ERSOT
DWM
HTC
BCI
Brevan Howard Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Brevan Howard Capital Management held 1,549 positions worth $10.4B, down 33% from $15.6B the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Brevan Howard Capital Management withdrew a net $5.08B in Q1 2025, closing 427 positions and reducing 229 holdings. Its most notable exit was iShares Ethereum Trust ETF, an estimated $94.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 4.6% of assets, up from 2% a quarter earlier, followed by Financials and Industrials.
Against the trend, Brevan Howard Capital Management opened a new position in Blackrock worth $41.2M.
- Brevan Howard Capital Management's largest Q1 2025 buy was Blackrock: 43,499 shares worth $41.2M.
- Brevan Howard Capital Management added most to Apple in Q1 2025, an estimated $83.9M increase.
- Brevan Howard Capital Management's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $212M.
- Brevan Howard Capital Management fully exited iShares Ethereum Trust ETF in Q1 2025, selling an estimated $94.2M.
- Brevan Howard Capital Management's ten largest holdings make up 73% of its $10.4B portfolio in Q1 2025.
- Brevan Howard Capital Management opened 555 new positions and closed 427 in Q1 2025.
- Brevan Howard Capital Management's portfolio value fell 33% quarter-over-quarter to $10.4B.
Based on Brevan Howard Capital Management's 13F filing for Q1 2025, filed 15 May 2025.